C207 Task 2 - Decision Tree Analysis for Business Decision Making
Data-Driven Decision Making (C207) Western Governors University
QUM3 – Task 2 – Decision Tree Analysis
Western Governors University
C207 – Data-Driven Decision Making
Name:
2026
, Table of Contents
A. Business Scenario Summary........................................................................................3
A1. Business Question.....................................................................................................3
A2. Justification...............................................................................................................3
B. Relevant Data Values......................................................................................................4
C. Decision Tree Diagram...................................................................................................4
D. Implications Summary....................................................................................................6
D1. Steps in Determining Expected Value......................................................................6
D2. Limitations................................................................................................................6
E. Recommended Course of Action....................................................................................7
References............................................................................................................................8
A. Business Scenario Summary
MPC is a pharmaceutical company currently working with a market research firm to
determine the best strategic direction for its drug products. The company is evaluating
three potential courses of action: developing a completely new drug line, finding new
therapeutic uses for an existing drug, or maintaining the current product line without
any changes. A new drug is currently under review and may receive regulatory approval
in the near future. If the market responds favorably, both the new drug and the
expanded use of the existing drug could generate strong sales. However, if the market is
Data-Driven Decision Making (C207) Western Governors University
QUM3 – Task 2 – Decision Tree Analysis
Western Governors University
C207 – Data-Driven Decision Making
Name:
2026
, Table of Contents
A. Business Scenario Summary........................................................................................3
A1. Business Question.....................................................................................................3
A2. Justification...............................................................................................................3
B. Relevant Data Values......................................................................................................4
C. Decision Tree Diagram...................................................................................................4
D. Implications Summary....................................................................................................6
D1. Steps in Determining Expected Value......................................................................6
D2. Limitations................................................................................................................6
E. Recommended Course of Action....................................................................................7
References............................................................................................................................8
A. Business Scenario Summary
MPC is a pharmaceutical company currently working with a market research firm to
determine the best strategic direction for its drug products. The company is evaluating
three potential courses of action: developing a completely new drug line, finding new
therapeutic uses for an existing drug, or maintaining the current product line without
any changes. A new drug is currently under review and may receive regulatory approval
in the near future. If the market responds favorably, both the new drug and the
expanded use of the existing drug could generate strong sales. However, if the market is
